Skip to Content

Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Protection Research Initiative Investigator Initiated Research-R01-Panel 2, Request for Applications (RFA) CD-04-002

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Protection Research Initiative Investigator Initiated Research—R01—Panel 2, Request for Applications (RFA) CD-04-002.

Times and Dates: 8 a.m.-8:30 a.m., August 11, 2004 (Open). 8:30 a.m.-5 p.m., August 11, 2004 (Closed). 8 a.m.-5 p.m., August 12, 2004 (Closed).

Place: Westin Peachtree Plaza Hotel, 210 Peachtree Street, NW., Atlanta, GA 30303, Telephone 404-659-1400.

Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Health Protection Research Initiative Investigator Initiated Research—R01—Panel 2, Request for Applications (RFA) CD-04-002.

Contact Person for More Information: Joan F. Karr, PhD., Scientific Review Administrator, Public Health Practice Program Office, CDC, 4770 Buford Highway, MS-K38, Atlanta, GA 30314, 770-488-2597.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: July 15, 2004.

Joseph E. Salter,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

End Signature End Preamble

[FR Doc. 04-16670 Filed 7-21-04; 8:45 am]

BILLING CODE 4163-18-P